Company: CWAN
Filing Date: 2025-03-20
Form Type: 424B3
Source: 0001193125-25-058975
Chunk: 245

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-03-20
Form: 424B3
Chunk 245
---
 validity or enforceability thereof), or (iv) any action asserting a claim governed by the 
 internal affairs doctrine.                                                                                                                                                                                                                      |     | the fullest extent permitted by law, the Court of Chancery of the State of Delaware (or, if the court of Chancery does not have jurisdiction, another state court located within the State of Delaware or, if no state court located                
 within the State of Delaware has jurisdiction, the federal district court for the District of Delaware) shall be the sole and exclusive forum for: (i) any derivative action or proceeding brought on behalf of Clearwater, (ii) any action         
 asserting a claim of breach of a fiduciary duty owed by any current or former director, officer or other employee of Clearwater to Clearwater or its stockholders, (iii) any action asserting a claim against Clearwater or any director or officer 
 of Clearwater arising pursuant to any provision of the DGCL, the Clearwater Charter or the Clearwater Bylaws, (iv) any action to interpret, apply, enforce or determine the validity of the Clearwater Charter or the Clearwater Bylaws,            
 (v) any action asserting a claim governed by the internal affairs doctrine or (vi) any other action asserting an “internal corporate claim” as that term is defined in Section 115 of the DGCL, in each case subject to the                         
 Court of Chancery of the State of Delaware having personal jurisdiction over the indispensable parties named as defendants therein.                                                                                                                 |

175

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT OF ENFUSION The following table sets forth information, as of February 5, 2025, about the beneficial ownership of Enfusion Common Stock and Enfusion Class B Common Stock held by (i) each person who is known to own beneficially more than 5% of Enfusion Common Stock or Enfusion Class B Common Stock, (ii) each Enfusion director, (iii) each Enfusion named executive officer and (iv) all directors and executive officers of Enfusion as a group. Applicable percentage ownership is based on 94,769,479 shares of Enfusion Common Stock and 34,198,767 shares of Enfusion Class B Common Stock outstanding as of February 5, 2025. Unless otherwise indicated, the address of each beneficial owner listed in the table below is c/o Enfusion, Inc., 125 South Clark Street, Suite 750, Chicago, IL 60603.

|                                                                            |